NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth

An overview on Vadimezan (DMXAA): The vascular disrupting agent

(2018) Amir Daei Farshchi Adli et al.   Chemical Biology & Drug Design

Tumor target amplification: Implications for nano drug delivery systems

(2018) Khaled Seidi et al.   JOURNAL OF CONTROLLED RELEASE

Tumor vascular infarction: prospects and challenges

(2017) Rana Jahanban-Esfahlan et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Combination of nanotechnology with vascular targeting agents for effective cancer therapy

(2017) Rana Jahanban-Esfahlan et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Modulating tumor hypoxia by nanomedicine for effective cancer therapy

(2017) Rana Jahanban-Esfahlan et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation

(2017) Khaled Seidi et al.   TUMOR BIOLOGY

RGD delivery of truncated coagulase to tumor vasculature affords local thrombotic activity to induce infarction of tumors in mice

(2017) Rana Jahanban-Esfahlan et al.   Scientific Reports

The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes

(2016) G.C.P. van Zundert et al.   JOURNAL OF MOLECULAR BIOLOGY

Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation

(2016) Tahereh Javaheri et al.   Cell Death & Disease

NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor

(2016) Caroline Brand et al.   Oncotarget

Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model

(2016) Tsion Zewdu Minas et al.   Oncotarget

The I-TASSER Suite: protein structure and function prediction

(2015) Jianyi Yang et al.   NATURE METHODS

YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model

(2015) Tsion Zewdu Minas et al.   Oncotarget

Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions

(2014) Naveen S. Vasudev et al.   ANGIOGENESIS

Contributions of thrombin targets to tissue factor-dependent metastasis in hyperthrombotic mice

(2013) N. Yokota et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Coagulases as Determinants of Protective Immune Responses against Staphylococcus aureus

(2012) Molly McAdow et al.   INFECTION AND IMMUNITY

Tumor Vasculature Targeting Through NGR Peptide-Based Drug Delivery Systems

(2011) Angelo Corti et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Contribution of Coagulases towards Staphylococcus aureus Disease and Protective Immunity

(2010) Alice G. Cheng et al.   PLoS Pathogens

Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience

(2009) R. Bieker et al.   BLOOD

The neovasculature homing motif NGR: more than meets the eye

(2008) A. Corti et al.   BLOOD

Integrin αvβ3-targeted cancer therapy

(2008) Zhaofei Liu et al.   DRUG DEVELOPMENT RESEARCH

A fusion protein containing murine vascular endothelial growth factor and tissue factor induces thrombogenesis and suppression of tumor growth in a colon carcinoma model

(2008) Feng-ying Huang et al.   Journal of Zhejiang University-SCIENCE B

Spatial localization of bacteria controls coagulation of human blood by 'quorum acting'

(2008) Christian J Kastrup et al.   Nature Chemical Biology